As industry experts predict that organizations should brace for increased health care costs in 2023, the International Foundation of Employee Benefit Plans launched a survey of U.S employers to identify the considerations they are contemplating for the coming year. Results show that corporate employers project a median increase of 7.5% for medical plan costs.

Causes of Cost Increases

Plan sponsors shared their thoughts on the primary reason contributing to a rise in health care costs, including the following.

  • Catastrophic claims—19%
  • Utilization due to chronic health conditions—15%
  • Utilization due to delayed preventive/elective care during the pandemic—12%
  • Medical provider costs—11%
  • Specialty/costly prescription drugs—7%

When employers were asked about health care claims in May 2021 (Employee Benefits in a COVID-19 World—One-Year Update), most noted a significant or slight decrease in employees pursuing elective procedures, preventive care, primary care appointments and emergency room visits due to the pandemic.

When discussing the results with Julie Stich, VP of Content at the International Foundation, she said that looking at the data from the last 18 months, the trend suggests that delaying routine care has resulted in poorer health and well-being, in turn leading to increased claims for both chronic and catastrophic conditions.

Managing Costs

When asked what types of initiatives would make the most impact on managing costs for 2023, employers indicated the following:

  • 24%—Purchasing/provider initiatives (e.g., telemedicine, price transparency tools, centers of excellence, health care navigators/advocates, coalitions, quality initiatives)
  • 22%—Cost-sharing initiatives (e.g., deductibles, coinsurance, copays, premium contributions)
  • 12%—Utilization control initiatives (e.g., prior authorization, case management, disease management, nurse advice lines)
  • 12%—Plan design initiatives (e.g., dependent eligibility audits, high-deductible health plans, wellness initiatives, spousal surcharges/carve-outs)

The top response includes telemedicine, which continues to grow as a popular benefit offering. An additional 9% of employers added telehealth services since the COVID-19 outbreak, according to the Employee Benefits in a COVID-19 World report.

Stich also said that it was interesting to note that employers are open to a wide range of options to best manage increased costs. The tight labor market has made many employers hesitant to increase employees’ portion of the benefit cost coverage. A combination of value solutions may be an ideal cost management technique for many organizations.

Visit www.ifebp.org/healthcarecosts for more information and a copy of the full survey results.

The Latest From the Word on Benefits:

Cara McMullin

Communications Specialist

Favorite Foundation Product: Word on Benefits Blog

Benefits-related Topics That Interest Her Most: Equity and Inclusion, Workplace Wellness

Personal Insight: Cara loves live theatre, concerts, and festivals – lots of fantastic options in Wisconsin. In her spare time, you can also find her reading, streaming TV/movies and spending time with family and friends at local restaurants, outdoor concerts, and farmers markets.

Recommended Posts

Open pharmacy pill containers on a pile of 20 dollar bills.

What the Executive Order Increasing PBM Fee Transparency Means for Employers

Amanda Wilke, CEBS
 

On April 15, 2025, President Trump signed the executive order (EO) “Lowering Drug Prices by Once Again Putting Americans First,” which includes specific actions to be taken by federal agencies to reduce prescription drug costs, improve transparency and increase competition in the […]

GLP-1 Drug Coverage Continues to Rise in Canada 

Rebecca Plier
 

New Survey Data Reveals Prior Authorization or Other Utilization Management Strategies, Eligibility Requirements, Annual Maximum as Leading Cost Control Methods  A new survey report from the International Foundation of Employee Benefit Plans reveals updated Canadian employer coverage and cost-control mechanisms surrounding glucagon-like […]

GLP-1 Drugs Responsible for Over Ten Percent of Annual Claims 

Rebecca Plier
 

New Survey Data Reveals Rise of GLP-1 Drug Claims, With Utilization Management and Eligibility Requirements as Leading Cost-Control Mechanisms   A new survey report from the International Foundation of Employee Benefit Plans reveals updated U.S. employer coverage and claims representation surrounding glucagon-like peptide-1 […]